Patent: 9,642,872

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,642,872

Title:	Treatment of B-cell lymphoma with microRNA
Abstract:	The invention relates to microRNA-34a and related microRNAs for use in the treatment of B-cell lymphoma. Likewise it relates to microRNA-34a for use in the preparation of a medicament for the treatment of B-cell lymphoma, and for a method of treatment of B-cell lymphoma comprising administering microRNA-34a. These claims are based on the observation that microRNA-34a shows strong anti-proliferative effects when overexpressed in diffuse large B-cell lymphoma (gDLBCL) cell lines, or when delivered intratumorally or systemically in xenograft models of DLBCL.
Inventor(s):	Craig; Vanessa (Zurich, CH), Mueller; Anne (Dubendorf, CH)
Assignee:	UNIVERSITY OF ZURICH (Zurich, CH)
Application Number:	14/565,049
Patent Claims:	see list of patent claims

Details for Patent 9,642,872

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	1997-11-26	⤷ Try it Free	2030-09-30
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	2002-02-19	⤷ Try it Free	2030-09-30
Genentech, Inc.	RITUXAN HYCELA	rituximab and hyaluronidase human	Injection	761064	2017-06-22	⤷ Try it Free	2030-09-30
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.